Histiocytoma, Malignant Fibrous
"Histiocytoma, Malignant Fibrous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.
MeSH Number(s)
C04.557.450.565.590.425.360
C04.557.450.795.400
Concept/Terms
Histiocytoma, Malignant Fibrous- Histiocytoma, Malignant Fibrous
- Fibrous Histiocytoma, Malignant
- Fibrous Histiocytomas, Malignant
- Histiocytomas, Malignant Fibrous
- Malignant Fibrous Histiocytomas
- Malignant Fibrohistiocytic Tumors
- Fibrohistiocytic Tumor, Malignant
- Fibrohistiocytic Tumors, Malignant
- Malignant Fibrohistiocytic Tumor
- Tumor, Malignant Fibrohistiocytic
- Tumors, Malignant Fibrohistiocytic
- Malignant Fibrous Histiocytoma
Below are MeSH descriptors whose meaning is more general than "Histiocytoma, Malignant Fibrous".
Below are MeSH descriptors whose meaning is more specific than "Histiocytoma, Malignant Fibrous".
This graph shows the total number of publications written about "Histiocytoma, Malignant Fibrous" by people in Harvard Catalyst Profiles by year, and whether "Histiocytoma, Malignant Fibrous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2008 | 3 | 2 | 5 |
2009 | 2 | 0 | 2 |
2010 | 2 | 2 | 4 |
2011 | 2 | 1 | 3 |
2012 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2014 | 2 | 1 | 3 |
2017 | 0 | 1 | 1 |
2019 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
Below are the most recent publications written about "Histiocytoma, Malignant Fibrous" by people in Profiles.
-
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas. Brain Pathol. 2022 07; 32(4):e13037.
-
Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors. Oncogene. 2021 08; 40(32):5095-5104.
-
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms. Brain Pathol. 2021 07; 31(4):e12918.
-
TLE-1 immunoreactivity in angiomatoid fibrous histiocytoma: a potential diagnostic pitfall. Pathology. 2020 Oct; 52(6):722-725.
-
Intracranial Myxoid Mesenchymal Tumor with Rare EWSR1-CREM Translocation. Pediatr Neurosurg. 2019; 54(5):347-353.
-
Atypical central neurocytoma with novel EWSR1-ATF1 fusion and MUTYH mutation detected by next-generation sequencing. BMJ Case Rep. 2019 Jan 14; 12(1).
-
ALK Expression in Angiomatoid Fibrous Histiocytoma: A Potential Diagnostic Pitfall. Am J Surg Pathol. 2019 01; 43(1):93-101.
-
Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? Brain Pathol. 2018 03; 28(2):183-191.
-
Characterization of metastatic angiomatoid fibrous histiocytoma. J Pediatr Hematol Oncol. 2015 May; 37(4):e268-71.
-
Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology. Am J Clin Oncol. 2015 Feb; 38(1):98-102.